|
Volumn 48, Issue 2, 2007, Pages 93-98
|
The anti-emetic efficacy of maropitant (Cerenia™) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe: Paper
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIEMETIC AGENT;
MAROPITANT;
QUINUCLIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL;
ANIMAL DISEASE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOG;
DOG DISEASE;
EUROPE;
FEMALE;
MALE;
MULTICENTER STUDY;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VOMITING;
ANIMALS;
ANTIEMETICS;
DOG DISEASES;
DOGS;
EUROPE;
FEMALE;
MALE;
QUINUCLIDINES;
TREATMENT OUTCOME;
VOMITING;
CANIS FAMILIARIS;
|
EID: 33846804057
PISSN: 00224510
EISSN: 17485827
Source Type: Journal
DOI: 10.1111/j.1748-5827.2006.00321.x Document Type: Article |
Times cited : (60)
|
References (12)
|